Key statistics
On Monday, Karyopharm Therapeutics Inc (KPTI:NSQ) closed at 9.59, -12.74% below its 52-week high of 10.99, set on Feb 24, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 9.16 |
|---|---|
| High | 9.83 |
| Low | 8.75 |
| Bid | 8.96 |
| Offer | 12.21 |
| Previous close | 9.41 |
| Average volume | 585.55k |
|---|---|
| Shares outstanding | 18.34m |
| Free float | 17.25m |
| P/E (TTM) | -- |
| Market cap | 175.92m USD |
| EPS (TTM) | -16.60 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
- Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm to Participate in Baird's Biotech Discovery Series
More ▼
